Find Givinostat HCl manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

0

JDMF

0

EU WC

0

KDMF

0

NDC API

0

VMF

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

Canada

0

Australia

0

South Africa

0

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

Health Canada Patents

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 199657-29-9, Givinostat hcl, Givinostat (hydrochloride), Itf 2357, Z02132r2qq, Unii-z02132r2qq
Molecular Formula
C24H28ClN3O4
Molecular Weight
457.9  g/mol
InChI Key
QKSGNWJOQMSBEP-UHFFFAOYSA-N
FDA UNII
Z02132R2QQ

Givinostat HCl
Histone Deacetylase Inhibitor is any substance that inhibits histone deacetylase, an enzyme that catalyzes the removal of acetyl groups from core histones. Inhibition of histone deacetylase can result in hyperacetylation of histones, with an effect on gene expression and cell differentiation.
1 2D Structure

Givinostat HCl

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[6-(diethylaminomethyl)naphthalen-2-yl]methyl N-[4-(hydroxycarbamoyl)phenyl]carbamate;hydrochloride
2.1.2 InChI
InChI=1S/C24H27N3O4.ClH/c1-3-27(4-2)15-17-5-7-21-14-18(6-8-20(21)13-17)16-31-24(29)25-22-11-9-19(10-12-22)23(28)26-30;/h5-14,30H,3-4,15-16H2,1-2H3,(H,25,29)(H,26,28);1H
2.1.3 InChI Key
QKSGNWJOQMSBEP-UHFFFAOYSA-N
2.2 Other Identifiers
2.2.1 UNII
Z02132R2QQ
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Itf 2357

2. Itf2357

2.3.2 Depositor-Supplied Synonyms

1. 199657-29-9

2. Givinostat Hcl

3. Givinostat (hydrochloride)

4. Itf 2357

5. Z02132r2qq

6. Unii-z02132r2qq

7. Itf2357 Hydrochloride

8. Itf-2357 Hydrochloride

9. Histone Deacetylase Inhibitor

10. Itf2357

11. Itf-2357

12. Carbamic Acid, N-[4-[(hydroxyamino)carbonyl]phenyl]-, [6-[(diethylamino)methyl]-2-naphthalenyl]methyl Ester, Hydrochloride (1:1)

13. [6-(diethylaminomethyl)naphthalen-2-yl]methyl N-[4-(hydroxycarbamoyl)phenyl]carbamate;hydrochloride

14. Carbamic Acid, N-(4-((hydroxyamino)carbonyl)phenyl)-, (6-((diethylamino)methyl)-2-naphthalenyl)methyl Ester, Hydrochloride (1:1)

15. (6-((diethylamino)methyl)naphthalen-2-yl)methyl (4-(hydroxycarbamoyl)phenyl)carbamate Hydrochloride

16. Mfcd28502062

17. {6-[(diethylamino)methyl]naphthalen-2-yl}methyl [4-(hydroxycarbamoyl)phenyl]carbamate Hydrochloride

18. Itf 2357 Hydrochloride

19. Givinostat Monohydrochloride

20. Schembl23529420

21. Givinostat Hydrochloride Anhydrous

22. Chebi:231333

23. Ex-a8024

24. Zha65729

25. Hy-14842a

26. Akos030526700

27. Cs-4728

28. Sb16937

29. As-52365

30. En300-257964

31. P14959

32. Q27294820

33. Z2327390266

34. (6-((diethylamino)methyl)naphthalen-2-yl)methyl 4-(hydroxycarbamoyl)phenylcarbamate Hydrochloride

35. [6-[(diethylamino)methyl]-2-naphthalenyl]methyl N-[4-[(hydroxyamino)carbonyl]phenyl]carbamate Hydrochloride (1:1)

36. {6-[(diethylamino)methyl]naphthalen-2-yl}methyl [4-(hydroxycarbamoyl)phenyl]carbamate--hydrogen Chloride

37. {6-[(diethylamino)methyl]naphthalen-2-yl}methyl N-[4-(hydroxycarbamoyl)phenyl]carbamate Hydrochloride

2.3.3 Other Synonyms

1. Givinostat

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 457.9 g/mol
Molecular Formula C24H28ClN3O4
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count5
Rotatable Bond Count9
Exact Mass Da
Monoisotopic Mass Da
Topological Polar Surface Area90.9
Heavy Atom Count32
Formal Charge0
Complexity575
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Histone Deacetylase Inhibitors

Compounds that inhibit HISTONE DEACETYLASES. This class of drugs may influence gene expression by increasing the level of acetylated HISTONES in specific CHROMATIN domains. (See all compounds classified as Histone Deacetylase Inhibitors.)


API SUPPLIERS

read-more
read-more

01

Chemi SpA

Italy

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

Chemi SpA

Italy

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF arrow-down Click Us! arrow-down
CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
blank

02

Chemvisai Labs

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

Chemvisai Labs

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

03

Erythro Pharma

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

Erythro Pharma

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

04

Angene International

United Kingdom

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

Angene International

United Kingdom

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

05

J&H CHEM

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

J&H CHEM

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

06

Tian Yuan Pharm

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

Tian Yuan Pharm

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

07

Taizhou Volsen Chemical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

Taizhou Volsen Chemical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-moreread-more

01

Chemi Spa

Italy

USDMF

arrow
AACR Annual meeting
Not Confirmed

01

Chemi Spa

Italy
arrow
AACR Annual meeting
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 37344

Submission : 2023-04-04

Status : Active

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

Angene International

United Kingdom
AACR Annual meeting
Not Confirmed
arrow

Angene International

United Kingdom
arrow
AACR Annual meeting
Not Confirmed

Givinostat

About the Company : Angene is pledged to providing quality chemicals for use in research and development and commercial manufacturing. Angenes offers over 100,000 products including lab reagents, inte...

Angene is pledged to providing quality chemicals for use in research and development and commercial manufacturing. Angenes offers over 100,000 products including lab reagents, intermediates, bulk commodities, agro-chemicals, natural ingredients and active pharmaceutical ingredients (APIs). In addition to the 100,000+ products, Angene offers custom synthesis of chemicals that are not commercially available.
blank

02

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Givinostat HCl

About the Company : Chemvisai Labs is a dynamic pharmaceutical partner established with a clear vision: to become a leading and trusted force in the industry. We address critical unmet medical needs t...

Chemvisai Labs is a dynamic pharmaceutical partner established with a clear vision: to become a leading and trusted force in the industry. We address critical unmet medical needs through our integrated expertise in Contract Research Organization (CRO) services, CARMS, New Chemical Entities (NCEs), and Generic APIs. Our core business encompasses comprehensive chemistry services and the manufacturing of essential Key Starting Materials (KSMs) and pharmaceutical intermediates.
blank

03

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Givinostat HCl

About the Company : Erythro Pharma specializes in large-scale custom chemical manufacturing for pharmaceutical, agrochemical, specialty and fine chemical sectors. The organization delivers integrated ...

Erythro Pharma specializes in large-scale custom chemical manufacturing for pharmaceutical, agrochemical, specialty and fine chemical sectors. The organization delivers integrated development-to-commercial services and supplies advanced API intermediates, specialty chemicals and fine chemicals in a cost-effective manner. With 30+ years of technical strength, strong safety practices and a robust raw-material supply network, Erythro Pharma supports global partners with reliable, high-quality solutions.
blank

04

J&H CHEM

China
AACR Annual meeting
Not Confirmed
arrow

J&H CHEM

China
arrow
AACR Annual meeting
Not Confirmed

Givinostat

About the Company : J&H CHEM is one of China's leading providers of integrated fine chemical services including offering, research and development, Custom manufacturing business, as well as other Valu...

J&H CHEM is one of China's leading providers of integrated fine chemical services including offering, research and development, Custom manufacturing business, as well as other Value-added customer services, for diversified range products of chemicals, pharmaceuticals, and specialities. As a highly customer-oriented enterprise, we always believe "Customer first, service foremost", put forward innovation, continuously improve pipeline, integrate our broad range of products and services with our technical expertise, customise a competitive package to meet our customers' specific needs.
blank

05

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Givinostat

About the Company : Taizhou Volsen Chemical Co., Ltd. is professional in R&D, producing and marketing Pharmaceutical raw materials, pharmaceutical intermediates in China. VOLSEN consists of about 100 ...

Taizhou Volsen Chemical Co., Ltd. is professional in R&D, producing and marketing Pharmaceutical raw materials, pharmaceutical intermediates in China. VOLSEN consists of about 100 experienced employees including 3 PhD and 10 Master, and 35000 sqm facilities including research laboratories, kilo lab, pilot plant and full manufacturing plant, VOLSEN R&D specialists, quality manager and sales with abundance experience make sure products are reliable and service is professional. The producing person inspect every step of the whole process and check up the quality strictly, in order to insure every batch of raw material achieve the standard of EP
blank

06

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Givinostat

About the Company : Tianyuan Pharmaceutical Co., Ltd. specializes in the research and development of targeted anticancer drugs and is dedicated to the exploration, production, and promotion of medical...

Tianyuan Pharmaceutical Co., Ltd. specializes in the research and development of targeted anticancer drugs and is dedicated to the exploration, production, and promotion of medical raw materials. The company's primary product line includes Crizotinib, Afatinib, Capmatinib, Aloitinib, Sorafenib, Ibrutinib, Lenvatinib, Mirogabalin, Omarigliptin, Peficitinib, as well as various other types of TINI API and intermediates.Tianyuan has established stable collaboration with amplification plants in Jiaozhou, Qingdao, facilitating the scaling up of production from 100kg to tonnage quantities.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more

Details:

Multicare Pharma will support the regulatory approval in Brazil and distribute Duvyzat (givinostat), Italfarmaco’s novel histone deacetylase (HDAC) inhibitor to treat Duchenne muscular dystrophy.


Lead Product(s): Givinostat HCl,Inapplicable

Therapeutic Area: Genetic Disease Brand Name: Duvyzat

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Multicare

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Agreement September 16, 2025

blank

01

AACR Annual meeting
Not Confirmed
AACR Annual meeting
Not Confirmed

Details : Multicare Pharma will support the regulatory approval in Brazil and distribute Duvyzat (givinostat), Italfarmaco’s novel histone deacetylase (HDAC) inhibitor to treat Duchenne muscular dystrophy.

Product Name : Duvyzat

Product Type : Miscellaneous

Upfront Cash : Undisclosed

September 16, 2025

blank

Details:

Duvyzat (givinostat HCl)is a histone deacetylase inhibitor indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 6 years of age and older.


Lead Product(s): Givinostat HCl,Inapplicable

Therapeutic Area: Genetic Disease Brand Name: Duvyzat

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable June 06, 2025

blank

02

AACR Annual meeting
Not Confirmed
AACR Annual meeting
Not Confirmed

Details : Duvyzat (givinostat HCl)is a histone deacetylase inhibitor indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 6 years of age and older.

Product Name : Duvyzat

Product Type : Miscellaneous

Upfront Cash : Inapplicable

June 06, 2025

blank

Details:

Duvyzat (givinostat HCl) is a histone deacetylase inhibitor, being investigated for the treatment of polycythaemia vera.


Lead Product(s): Givinostat HCl,Inapplicable

Therapeutic Area: Oncology Brand Name: Duvyzat

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable May 06, 2025

blank

03

AACR Annual meeting
Not Confirmed
AACR Annual meeting
Not Confirmed

Details : Duvyzat (givinostat HCl) is a histone deacetylase inhibitor, being investigated for the treatment of polycythaemia vera.

Product Name : Duvyzat

Product Type : Miscellaneous

Upfront Cash : Inapplicable

May 06, 2025

blank

Details:

Duvyzat (givinostat) is a novel histone deacetylase (HDAC) inhibitor, which is being evaluated for the treatment of patients 6 years or older with Duchenne muscular dystrophy.


Lead Product(s): Givinostat HCl,Inapplicable

Therapeutic Area: Genetic Disease Brand Name: Duvyzat

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable April 25, 2025

blank

04

AACR Annual meeting
Not Confirmed
AACR Annual meeting
Not Confirmed

Details : Duvyzat (givinostat) is a novel histone deacetylase (HDAC) inhibitor, which is being evaluated for the treatment of patients 6 years or older with Duchenne muscular dystrophy.

Product Name : Duvyzat

Product Type : Miscellaneous

Upfront Cash : Inapplicable

April 25, 2025

blank

Details:

Under the agreement, Medis will have exclusive distribution rights of Duvyzat (Givinostat HCl). It is being indicated for the treatment of DMD.


Lead Product(s): Givinostat HCl,Inapplicable

Therapeutic Area: Genetic Disease Brand Name: Duvyzat

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Medis

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Agreement March 18, 2025

blank

05

AACR Annual meeting
Not Confirmed
AACR Annual meeting
Not Confirmed

Details : Under the agreement, Medis will have exclusive distribution rights of Duvyzat (Givinostat HCl). It is being indicated for the treatment of DMD.

Product Name : Duvyzat

Product Type : Miscellaneous

Upfront Cash : Undisclosed

March 18, 2025

blank
  • Development Update

Details:

Givinostat HCl is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Muscular Dystrophy, Duchenne.


Lead Product(s): Givinostat HCl,Inapplicable

Therapeutic Area: Genetic Disease Brand Name: Undisclosed

Study Phase: Phase IIProduct Type: Miscellaneous

Sponsor: Fortrea

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable January 10, 2025

blank

06

Italfarmaco

Country
arrow
AACR Annual meeting
Not Confirmed

Italfarmaco

Country
arrow
AACR Annual meeting
Not Confirmed

Details : Givinostat HCl is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Muscular Dystrophy, Duchenne.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

January 10, 2025

blank

Details:

Duvyzat (givinostat) is a novel histone deacetylase (HDAC) inhibitor, which is being evaluated for the treatment of patients 6 years or older with Duchenne muscular dystrophy.


Lead Product(s): Givinostat HCl,Inapplicable

Therapeutic Area: Genetic Disease Brand Name: Duvyzat

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable July 25, 2024

blank

07

AACR Annual meeting
Not Confirmed
AACR Annual meeting
Not Confirmed

Details : Duvyzat (givinostat) is a novel histone deacetylase (HDAC) inhibitor, which is being evaluated for the treatment of patients 6 years or older with Duchenne muscular dystrophy.

Product Name : Duvyzat

Product Type : Miscellaneous

Upfront Cash : Inapplicable

July 25, 2024

blank

Details:

PANTHERx partners with ITF for the U.S. distribution of Duvyzat (givinostat), the approved product to treat patients with all genetic variants of Duchenne muscular dystrophy aged six years and older.


Lead Product(s): Givinostat HCl,Inapplicable

Therapeutic Area: Genetic Disease Brand Name: Duvyzat

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: ITF Therapeutics

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Partnership July 25, 2024

blank

08

AACR Annual meeting
Not Confirmed
AACR Annual meeting
Not Confirmed

Details : PANTHERx partners with ITF for the U.S. distribution of Duvyzat (givinostat), the approved product to treat patients with all genetic variants of Duchenne muscular dystrophy aged six years and older.

Product Name : Duvyzat

Product Type : Miscellaneous

Upfront Cash : Undisclosed

July 25, 2024

blank

Details:

Duvyzat (givinostat) is a novel histone deacetylase (HDAC) inhibitor, which is being evaluated for the treatment of patients 6 years or older with Duchenne muscular dystrophy.


Lead Product(s): Givinostat HCl,Inapplicable

Therapeutic Area: Genetic Disease Brand Name: Duvyzat

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable March 21, 2024

blank

09

AACR Annual meeting
Not Confirmed
AACR Annual meeting
Not Confirmed

Details : Duvyzat (givinostat) is a novel histone deacetylase (HDAC) inhibitor, which is being evaluated for the treatment of patients 6 years or older with Duchenne muscular dystrophy.

Product Name : Duvyzat

Product Type : Miscellaneous

Upfront Cash : Inapplicable

March 21, 2024

blank
  • Development Update

Details:

ITF2357 (givinostat) is an HDAC Inhibitor small molecule drug, currently being investigated as an oral suspension for the treatment of Duchenne Muscular Dystrophy.


Lead Product(s): Givinostat HCl,Inapplicable

Therapeutic Area: Genetic Disease Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable November 29, 2023

blank

10

The Italfarmaco Group

Country
arrow
AACR Annual meeting
Not Confirmed

The Italfarmaco Group

Country
arrow
AACR Annual meeting
Not Confirmed

Details : ITF2357 (givinostat) is an HDAC Inhibitor small molecule drug, currently being investigated as an oral suspension for the treatment of Duchenne Muscular Dystrophy.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

November 29, 2023

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Looking for 199657-29-9 / Givinostat HCl API manufacturers, exporters & distributors?

Givinostat HCl manufacturers, exporters & distributors 1

93

PharmaCompass offers a list of Givinostat HCl API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Givinostat HCl manufacturer or Givinostat HCl supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Givinostat HCl manufacturer or Givinostat HCl supplier.

API | Excipient name

Givinostat HCl

Synonyms

199657-29-9, Givinostat (hydrochloride), Itf 2357, Z02132r2qq, Unii-z02132r2qq, Itf2357 hydrochloride

Cas Number

199657-29-9

Unique Ingredient Identifier (UNII)

Z02132R2QQ

About Givinostat HCl

Histone Deacetylase Inhibitor is any substance that inhibits histone deacetylase, an enzyme that catalyzes the removal of acetyl groups from core histones. Inhibition of histone deacetylase can result in hyperacetylation of histones, with an effect on gene expression and cell differentiation.

Givinostat HCl Manufacturers

A Givinostat HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Givinostat HCl, including repackagers and relabelers. The FDA regulates Givinostat HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Givinostat HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Givinostat HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Givinostat HCl Suppliers

A Givinostat HCl supplier is an individual or a company that provides Givinostat HCl active pharmaceutical ingredient (API) or Givinostat HCl finished formulations upon request. The Givinostat HCl suppliers may include Givinostat HCl API manufacturers, exporters, distributors and traders.

click here to find a list of Givinostat HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Givinostat HCl USDMF

A Givinostat HCl DMF (Drug Master File) is a document detailing the whole manufacturing process of Givinostat HCl active pharmaceutical ingredient (API) in detail. Different forms of Givinostat HCl DMFs exist exist since differing nations have different regulations, such as Givinostat HCl USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Givinostat HCl DMF submitted to regulatory agencies in the US is known as a USDMF. Givinostat HCl USDMF includes data on Givinostat HCl's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Givinostat HCl USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Givinostat HCl suppliers with USDMF on PharmaCompass.

Givinostat HCl GMP

Givinostat HCl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Givinostat HCl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Givinostat HCl GMP manufacturer or Givinostat HCl GMP API supplier for your needs.

Givinostat HCl CoA

A Givinostat HCl CoA (Certificate of Analysis) is a formal document that attests to Givinostat HCl's compliance with Givinostat HCl specifications and serves as a tool for batch-level quality control.

Givinostat HCl CoA mostly includes findings from lab analyses of a specific batch. For each Givinostat HCl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Givinostat HCl may be tested according to a variety of international standards, such as European Pharmacopoeia (Givinostat HCl EP), Givinostat HCl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Givinostat HCl USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty